Lexeo Therapeutics, Inc. Common StockLXEONASDAQ
LOADING
|||
Cash Flow Performance
Trending lower, below historical average, strong compound growth.
Left:
||||
Free cash flow yield
Latest
-39.03%
↓ 102% below average
Average (4y)
-19.28%
Historical baseline
Range
High:-1.24%
Low:-39.03%
CAGR
+136.9%
Consistent expansion
| Period | Value | Change |
|---|---|---|
| 2024 | -39.03% | -133.9% |
| 2023 | -16.68% | +23.9% |
| 2022 | -21.93% | -25.0% |
| 2021 | -17.54% | -1316.0% |
| 2020 | -1.24% | - |